ANTI-ANDROGENIC DRUGS
Finasteride is a:
| A |
5 alpha reductase inhibitor |
|
| B |
PDE inhibitor |
|
| C |
Alpha la blocker |
|
| D |
Androgen receptor blocker |
Finasteride is a:
| A |
5 alpha reductase inhibitor |
|
| B |
PDE inhibitor |
|
| C |
Alpha la blocker |
|
| D |
Androgen receptor blocker |
Finasteride is a competitive inhibitor of the enzyme 5-alpha reductase which is responsible for the conversion of testosterone into a more active dihydrotestosterone responsible for the androgen action.
When used in benign prostatic hypertrophy, it reduces the prostate size and increased peak urinary flow rate.
It is also used in male pattern baldness and as a palliative treatment in prostatic carcinoma.
Ref: K D Tripathi Textbook of Pharmacology, 5th Edition, Page 272
Anti androgen used in heart failure ‑
| A |
Carvedilol |
|
| B |
Sampatrilat |
|
| C |
Spironolactone |
|
| D |
Abiraterone |
Anti androgen used in heart failure ‑
| A |
Carvedilol |
|
| B |
Sampatrilat |
|
| C |
Spironolactone |
|
| D |
Abiraterone |
Ans. is ‘c’ i.e., Spironolactone
o Spironolactone and eplerenone are the aldosterone antagonists. They are used as potassium sparing diuretics. Their diurectic effect is quite feeble, but in CHF these drugs reduce the mortality (at doses lower than diuretic doses) by antagonizing the effect of aldosterone (reversal of remodelling). Spironolactone also possesses anti- androgenic effects.
Bicalutamide is a specific inhibitor of –
| A |
5-alpha reductase |
|
| B |
Androgen receptors |
|
| C |
Aromatase |
|
| D |
Estrogen receptor |
Bicalutamide is a specific inhibitor of –
| A |
5-alpha reductase |
|
| B |
Androgen receptors |
|
| C |
Aromatase |
|
| D |
Estrogen receptor |
Ans. is ‘b’ i.e., Androgen receptors
Androgen receptor blocking drug is-
| A |
Tamoxifen |
|
| B |
Cyproterone acetate |
|
| C |
Mifepristone |
|
| D |
Nalondrone |
Androgen receptor blocking drug is-
| A |
Tamoxifen |
|
| B |
Cyproterone acetate |
|
| C |
Mifepristone |
|
| D |
Nalondrone |
Ans. is ‘b’ i.e., Cyproterone acetate
A teenager girl with moderate acne is also complaining of irregular menses. Drug of choice will be:
| A |
Oral isotretinon |
|
| B |
Oral acitretin |
|
| C |
Oral minocycline |
|
| D |
Cyproterone acetate |
A teenager girl with moderate acne is also complaining of irregular menses. Drug of choice will be:
| A |
Oral isotretinon |
|
| B |
Oral acitretin |
|
| C |
Oral minocycline |
|
| D |
Cyproterone acetate |
D i.e. Cyproterone acetate
Cyproterone acetate is a progestin and a weak anti androgen by virtue of binding to the androgen receptor (i.e. progestational antiandrogen that blocks androgen receptor). Because of antiandrogen action, it is efective in conditions like acne seborrhoea, hirsutism, female pattern hair loss (androgenetic hair loss in females), hidreadinitis suppurativaQ -i.e. conditions caused or aggravated by androgenic hormones.
– Cyproterone acetate (CPA) is effective in treatment of acne as it reduces sebum production (dose dependent) & comedogenesis. In premenopausal women it is usually combined with ethinyloestradiol (Dianette & estelle 35) or other oral contraceptive agents to regulate menstrual cycle irregularitiesQ (caused by high dose cyproterone) and prevent pregnancy (d/t concerns of feminising effects of cyproterone on male fetus). Whereas, in postmenopausal women, it is not necessary to combine ethinyl oestradiol (EOD) with CPA.
Reverse sequential regimen (CPA 100 mg / day on days 5 to 15, and EOD 30-50 mg /day on cycle days 5to 26) regulates menstrual bleeding, provides excellent contraception and is effective in treatment of even severe hirsutism and acneQ. Acne usually improves 40-50% by 3rd and 80-90% by 9th cycle.
The following statements regarding finasteride are true except
| A |
It is used in the medical treatment of Benign prostatic hypertrophy |
|
| B |
Impotence is well documented after its use |
|
| C |
It blocks the conversion of dihydrotestosterone to testosterone |
|
| D |
It is a 5-oc reductase inhibitor |
The following statements regarding finasteride are true except
| A |
It is used in the medical treatment of Benign prostatic hypertrophy |
|
| B |
Impotence is well documented after its use |
|
| C |
It blocks the conversion of dihydrotestosterone to testosterone |
|
| D |
It is a 5-oc reductase inhibitor |
Ans. is ‘c’ i.e. It blocks the conversion of dihydrotestosterone to testosterone
- Finasteride is a 5 a-reductase inhibitor which blocks the conversion of testosterone to its more active form dihydrotestosterone
- Uses
- BPH – decreases the size of large prostate (> 40 cm3) and can retard disease progression.
- Male pattern baldness – in patients of male pattern baldness, it promotes hair growth and prevents further hair loss.
Side effects
a) Impotence: is a well documented although infrequent side effect.
b) Decreased libido
c) Decreased volume of ejaculate
d) Skin rashes
e) Swelling of lips
Which is not used in carcinoma prostate ‑
| A |
Estrogen |
|
| B |
Progesterone |
|
| C |
Cyproterone acetate |
|
| D |
Flutamide |
Which is not used in carcinoma prostate ‑
| A |
Estrogen |
|
| B |
Progesterone |
|
| C |
Cyproterone acetate |
|
| D |
Flutamide |
Ans. is ‘c’ i.e., Conservative treatment
An old man is having benign prostatic hypertrophy. Drug useful in such a patient would be:
March 2012
| A |
Cyproterone acetate |
|
| B |
Danazol |
|
| C |
Bicalutamide |
|
| D |
Finasteride |
An old man is having benign prostatic hypertrophy. Drug useful in such a patient would be:
March 2012
| A |
Cyproterone acetate |
|
| B |
Danazol |
|
| C |
Bicalutamide |
|
| D |
Finasteride |
Ans: D i.e. Finasteride
Drugs and uses
- Cyproterone has been clinically tested in precocious puberty in boys, inappropriate sexual behaviour in men, acne and virilisation in women, but is not marketed.
- Danazol is useful in endometriosis, menorrhagia, fibrocystic breast disease and hereditary angioneurotic edema.
- Bicalutamide (more potent and longer acting congener of flutamide) is suitable for once daily administration in metastatic carcinoma of prostrate.
- Treatmentt with finasteride has resulted in decreased prostate size and increased peak urinary flow rate in nearly 50% patients with symptomatic benign hypertrophy of the prostrate (BHP). It is the only drug which can retard disease progression.
Flutamide is used in CA ‑
| A |
Cervix |
|
| B |
Prostate |
|
| C |
Kidneys |
|
| D |
Liver |
Flutamide is used in CA ‑
| A |
Cervix |
|
| B |
Prostate |
|
| C |
Kidneys |
|
| D |
Liver |
Ans. is ‘b’ i.e., Prostate
Flutamide
- It is a nonsteroidal drug.
- Has antiandrogenic but no other hormonal activity.
- Its active metabolite 2-hydroxyflutamide competitively blocks androgen action on accessory sex organs as well as on pituitary – inceases LH secretion by blocking feed back inhibition – testosterone secretion increases which partially overcome the direct antiandrogenic action.
- It is used in metastatic prostatic carcinoma.
- It is better used in conjuction with GnRH agonist to suppress LH and testosterone secretion.
- Reports of liver damage have restricted its use.
Antiandrogen pill contains ‑
| A |
Cyproterone acetate |
|
| B |
Clomiphene citrate |
|
| C |
Letrozole |
|
| D |
None |
Antiandrogen pill contains ‑
| A |
Cyproterone acetate |
|
| B |
Clomiphene citrate |
|
| C |
Letrozole |
|
| D |
None |
Ans. is ‘a’ i.e., Cyproterone acetate
- Combined with ethinyl estrodiol, cyproterone acetate comes as combination form of birth control pill prescribed to women for its antiandrogenic effect to treat :‑
- Hair loss (female pattern).
- Acne
- Hirsutism
- Seborrhoea
- Hidradenitis suppurativa




